Prognostic relevance of NG2/CSPG4, CD44 and Ki-67 in patients with glioblastoma.
Tsidulko AY, Kazanskaya GM, Kostromskaya DV, Aidagulova SV, Kiselev RS, Volkov AM, Kobozev VV, Gaitan AS, Krivoshapkin AL, Grigorieva EV.
Tsidulko AY, et al. Among authors: kazanskaya gm.
Tumour Biol. 2017 Sep;39(9):1010428317724282. doi: 10.1177/1010428317724282.
Tumour Biol. 2017.
PMID: 28945172
Free article.